iTeos Therapeutics Statistics
Total Valuation
ITOS has a market cap or net worth of $390.33 million. The enterprise value is -$132.22 million.
| Market Cap | 390.33M |
| Enterprise Value | -132.22M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ITOS has 35.84 million shares outstanding. The number of shares has decreased by -5.30% in one year.
| Shares Outstanding | 35.84M |
| Shares Change (YoY) | -5.30% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.54% |
| Owned by Institutions (%) | 102.45% |
| Float | 24.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.56 |
| PS Ratio | 31.28 |
| Forward PS | n/a |
| PB Ratio | 0.68 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.76, with a Debt / Equity ratio of 0.01.
| Current Ratio | 13.76 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.40% and return on invested capital (ROIC) is -25.99%.
| Return on Equity (ROE) | -18.40% |
| Return on Assets (ROA) | -16.20% |
| Return on Capital (ROIC) | -25.99% |
| Revenue Per Employee | $80,223 |
| Profits Per Employee | -$717,465 |
| Employee Count | 157 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ITOS has paid $3.61 million in taxes.
| Income Tax | 3.61M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.11% in the last 52 weeks. The beta is 1.19, so ITOS's price volatility has been higher than the market average.
| Beta (1Y) | 1.19 |
| 52-Week Price Change | -18.11% |
| 50-Day Moving Average | 11.36 |
| 200-Day Moving Average | 11.22 |
| Relative Strength Index (RSI) | 44.39 |
| Average Volume (30 Days) | 279,512 |
Short Selling Information
The latest short interest is 2.05 million, so 5.71% of the outstanding shares have been sold short.
| Short Interest | 2.05M |
| Short Previous Month | 2.01M |
| Short % of Shares Out | 5.71% |
| Short % of Float | 8.26% |
| Short Ratio (days to cover) | 7.41 |
Income Statement
In the last 12 months, ITOS had revenue of $12.60 million and -$112.64 million in losses. Loss per share was -$3.15.
| Revenue | 12.60M |
| Gross Profit | 12.60M |
| Operating Income | -151.10M |
| Pretax Income | -109.03M |
| Net Income | -112.64M |
| EBITDA | -108.13M |
| EBIT | -109.03M |
| Loss Per Share | -$3.15 |
Balance Sheet
The company has $532.19 million in cash and $6.06 million in debt, giving a net cash position of $526.13 million or $14.68 per share.
| Cash & Cash Equivalents | 532.19M |
| Total Debt | 6.06M |
| Net Cash | 526.13M |
| Net Cash Per Share | $14.68 |
| Equity / Book Value | 575.23M |
| Book Value Per Share | 16.05 |
| Working Capital | 510.64M |
Cash Flow
In the last 12 months, operating cash flow was -$103.76 million and capital expenditures -$2.97 million, giving a free cash flow of -$106.72 million.
| Operating Cash Flow | -103.76M |
| Capital Expenditures | -2.97M |
| Free Cash Flow | -106.72M |
| FCF Per Share | -$2.98 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,199.69% and -894.34%.
| Gross Margin | 100.00% |
| Operating Margin | -1,199.69% |
| Pretax Margin | -865.66% |
| Profit Margin | -894.34% |
| EBITDA Margin | -858.53% |
| EBIT Margin | -865.66% |
| FCF Margin | -847.34% |
Dividends & Yields
ITOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.30% |
| Shareholder Yield | 5.30% |
| Earnings Yield | -28.60% |
| FCF Yield | -27.09% |
Analyst Forecast
The average price target for ITOS is $33.25, which is 202.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $33.25 |
| Price Target Difference | 202.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 103.30% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ITOS has an Altman Z-Score of 3.22 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.22 |
| Piotroski F-Score | 1 |